Press

Press
Concerning ethnic disparities in access to safe COVID-19 treatment
British Bangladeshi men have highest rates of lung cancer in England
Largest ever UK study reveals stark ethnic and social inequalities in lung cancer diagnosis
New QR4 algorithm outperforms previous models in predicting cardiovascular disease risk
How our research gave vaccine answers to people with blood cancer
Study shows disparity in COVID-19 vaccines uptake for immunocompromised individuals, despite evidence of vaccine effectiveness and safety
Excess weight had major impact on hospital resource use during the COVID-19 pandemic
New risk tool could identify people with new-onset diabetes at highest risk for pancreatic cancer
Assessing the safety of COVID-19 vaccination in children
Safety of COVID-19 vaccination in children
New model predicts risk of developing and dying from breast cancer within 10 years to aid personalised screening
New heart disease calculator could save lives by identifying high-risk patients missed by current tools
COVID-19 vaccines are safe and effective for people with blood cancer, study finds
New risk score for cardiovascular disease with improved performance
Teenagers are most likely to seek help for anxiety or depression at the start of the school year, says new study
New tool to predict people’s risks of getting oesophageal cancer
New study offers hope in early detection of oesophageal cancer
New model could offer personalised breast cancer screening approach, say experts
Clever new tool predicts your risk of developing lung cancer
New tool to predict people's risk of developing lung cancer within the next ten years
Oxford Uni say lives could be saved by a new tool that identifies those at risk of developing lung cancer
Tool Predicts Lung Cancer Risk from Health Records
New tool can spot those most at risk of developing lung cancer, say researchers (2)
New tool can spot those most at risk of developing lung cancer, say researchers (1)
New tool can spot those most at risk of developing lung cancer, say researchers
New tool uses health records to predict risk of developing lung cancer within the next 10 years
New tool uses existing health records to predict people’s risk of developing lung cancer within the next 10 years
Nottingham researchers help deliver new tool to predict people’s risk of developing lung cancer within the next 10 years
Optimising eligibility criteria for lung cancer screening. by Philip Crosbie, Matthew Callister
New Oxford and Nottingham developed tool uses existing health records to predict people’s risk of developing lung cancer within the next 10 years
GPs prescribing antidepressants to children against guidelines
Only a QUARTER of children given antidepressants saw a psychiatrist beforehand: GPs 'often' break NHS rules in doling out the powerful drugs
GPs giving antidepressants to children against guidelines
Antidepressants for children and teenagers: what works for anxiety and depression?
Preexisting Neuropsychiatric Conditions and Associated Risk of Severe COVID-19 Infection and Other Acute Respiratory Infections
Teens and antidepressants, stamp duty savings and earthquake probabilities
Signs and symptoms of pancreatic cancer
Symptoms awareness: Raising awareness of the symptoms of pancreatic cancer?
Myocarditis Risk Low Overall After COVID-19 Vax, but Higher in Some Groups
Time-varying nature of clinical risk factors for pancreatic cancer may aid earlier diagnosis
Early detection innovation award for Oxford researchers
COVID-19 vaccine protects people of all body weights from hospitalisation and death, study of 9 million adults in England suggests
ARC East Midlands videos used by award-winning team
Campaign to raise awareness of dementia risk linked to type of drug
JAMA Network Articles of the Year 2019
Science and Innovation at Cancer Research UK
Toothbrushes and ctDNA: Exciting early detection concepts from new teams formed at our sandpit workshops
Our Open Access Publication of the Month - January 2022
AstraZeneca: A Vaccine for the World?
OX153 Twitter Update
New study shows risk of heart inflammation following COVID-19 infection and vaccination
Improving the health of the nation through data insights
Concern over dip in cancer diagnoses among children during pandemic (1)
Concern over dip in cancer diagnoses among children during pandemic
Alarm over ‘serious’ delays in diagnosing childhood cancer in England
Covid vaccines associated with rare neurological complications, says study
What you need to know about COVID-19 vaccines and rare neurological complications
Greater risk for neurological complications from COVID-19 infection vs. vaccination, analysis shows
AstraZeneca vaccine and Covid both linked to increased risk of Guillain-Barré syndrome
Covid linked to higher risk of neurological complications than vaccines, study finds
Covid vaccine linked to risk of health issues like stroke
‘Covid-19 presents greater risk of rare neurological events than vaccines’
Covid: Vaccine study links virus to rare neurological illness
Covid-19 more likely to cause neurological issues than vaccines, study finds
Risk of debilitating nerve syndrome almost four times higher from Covid than vaccine
AstraZeneca and Pfizer vaccines associated with rare but potentially serious side effects in study
COVID-19 infection has greater risk of causing very rare neurological events than vaccines
Pancreatic cancer early detection funds awarded to department researchers
Covid research partnership wins national computing innovation award
Vaccinated groups at highest risk of Covid-19 hospitalisation and death identified using new QCovid tool
Age, illness and vaccine status still biggest factors as new Covid calculator shows who’s most at risk
People with Down's syndrome and severe kidney disease are most at risk of being admitted to hospital or death after having two Covid vaccines, study finds
Researchers unveil algorithm to identify COVID-19 patients at high risk despite vaccination
Calculator reveal which vaccinated Brits are most at risk of dying from Covid
Men 'more likely' to face severe outcomes following double-vaccination, warns new study
Older people and men 'more likely to suffer' with Covid even after two jabs
Study Identifies Groups Still At Risk of Severe COVID Despite Vaccination
Researchers identify vaccinated patient groups most at risk of serious Covid
People with chronic conditions among most at risk from Covid even after jabs
Covid travel news: Government to introduce charges for tests, as bookings surge after rules eased
New tool identifies groups most at-risk from Covid after vaccination
COVID-19: QCovid tool's new algorithm identifies those most at-risk from coronavirus after vaccination
Menopause hormone replacement therapy ‘does not raise dementia risk’
Menopausal hormone therapy and dementia
HRT not linked to increased risk of dementia, says study
Study finds no link between menopausal hormone therapy and increased risk of dementia
QCovid highly commended for ‘best use of technology in Patient Safety’ at the 2021 HSJ Patient Safety Awards
Covid-19, not vaccination, presents biggest blood clot risks 27th August 2021
COVID-19 risk prediction tool wins national award
QResearch reveals ethnic minority children more likely to test positive for COVID-19
Model that predicts patient risk from COVID-19 wins Florence Nightingale Award for Excellence in Healthcare Data Analytics
Heart Best Paper Award 2021
Ethnic minority children may be disproportionately impacted by Covid-19 - study
Oxford-led technology to help those at high risk from Covid-19
EDRA Newsletter Spring 2021
Asthma Not A Major Risk Factor For Severe Covid
DART Press Release Lung Health Checks 13th July 2020
QResearch database researchers collaboration on two major cancer projects 07/07/2020
UKRI invests £13m in life saving projects 03/07/2020
DELTA project Cambridge and Oxford awarded government funding to speed up cancer diagnoses 03/07/2020
Health Data Research UK selects 12 projects to accelerate use of data for vital COVID-19 research
COVID-19 is 10 times deadlier for people with Down syndrome, raising calls for early vaccination
Teenagers' use of antidepressants is rising with variations across regions and ethnic groups
Early stage ‘red flag’ symptoms for pancreatic cancer
New risk model estimates likelihood of hospitalisation or death from COVID-19 21st October 2020
Study linking together COVID-19 patient data awarded funding 7th April 2020
Study provides new estimates of breast cancer risks associated with HRT
Study gets go-ahead to investigate COVID-19 and ethnicity
QResearch database researchers collaborate on two major cancer projects
Development and evaluation of a tool for predicting risk of short-term adverse outcomes due to COVID-19 in the general UK population; Press Release
QResearch joins Oxford-led consortium for liver cancer early detection 31/01/2020
JAMA Network Articles of the Year 2019 - QResearch Study Has Second Highest Read Rate of 2019 03/12/2019
HRT and risk of thrombosis (blood clots) 09/01/2019
DOACs’ safety affirmed in real-world setting (9 July 2018)
The risks and benefits of modern anticoagulant drugs (5 July 2018)
New anti-clotting drugs linked to lower risk of serious bleeding (4 July 2018)
New anti-clotting drugs linked to lower risk of serious bleeding (BMJ) (4 July 2018)
Real life GP data powers major anticoagulants study (21 June 2018)
Potential risks of antidepressants (7 May 2018)
Adverse effects of antidepressants in younger adults (20 April 2018)
Antidepressant Types Linked to Different Adverse Outcomes in Adults with Depression (2 April 2018)
New research will help fight diabetes (20 December 2017)
Frailty calculator to support GPs in targeting patients for better care (21 September 2017)
New web calculator to more accurately predict bowel cancer survival (EMIS) (20 June 2017)
New web calculator to more accurately predict bowel cancer survival (16 June 2017)
QRISK tool picks up more patients at risk of heart disease (30 May 2017)
GPs' heart disease prediction tool narrows search for at-risk patients (24 May 2017)
QCancer Update - Macmillan Cancer Decision Support (CDS) Tool (8 December 2016)
Nottingham leads the world in research using information from primary healthcare (28 November 2016)
QResearch data reveals risks of clinical outcomes for diabetes drugs (31 March 2016)
Study compares risk of diabetes drugs and medical complications (30 March 2016)
SSRI antidepressants not associated with an increased risk of cardiovascular conditions (22 March 2016)
New QResearch tool helps GPs identify diabetes patients most at risk of blindness and amputation (12 November 2015)
New risk tools spot patients at high risk of diabetes complications (11 November 2015)
New evidence confirms link between newer contraceptive pills and higher clot risks (27 May 2015)
New QCancer tool rolled out to 4000 EMIS practices (3 March 2015)
QResearch new project looking at antidepressants safety published in BMJ (February 2015)
Some antidepressants may be linked with higher rates of suicide and self-harm, research finds (20 February 2015)
QResearch- how you can help CVD prevention diagnosis and treatment in the UK
Hippisley-Cox wins John Perry Prize for pseudonymisation tools made available by QResearch (29 October 2013)
New QResearch tool to improve stroke treatment (15 May 2013)
Nottingham role in monitoring the health of the nation during 2012 London Olympics (11 February 2013)
Smoking and diabetes studies win health innovation grant (21 January 2013)
EMIS Web integrates diabetes tool (10 January 2013)
QDiabetes risk assessment tool to help GPs prevent diabetes (17 December 2012)
QResearch marks ten years with a 10K award (4 October 2012)
National recognition for cancer diagnosis tool (13 June 2012 PA 166/12)
Bowel cancer risk calculator could help doctors diagnose the disease (Cancer Research UK, 11 July 2012)
QRisk2 international app released for the iPhone/iPad (7 February 2012 PA 41/12)
QCancer may be built into GP systems (9 January 2012)
Simple online tool to aid GPs in early ovarian cancer diagnosis (4 January 2012 PA 01/12)
Simple test to help diagnose bowel and pancreatic cancer could save thousands of lives (14 December 2011 PA 387/11)
Computer-based tool to improve diagnosis and prognosis for cancer patients (31 October 2011 PA 336/11)
New QResearch tool to improve diagnosis and treatment of cancer (31 October 2011)
QResearch data used for new antidepressant study (4 August 2011)
New risk score spots patients at high risk of serious blood clots (17 August 2011 PA 245/11)
QThrombosis to help tackle leading cause of UK deaths (17 August 2011)
New antidepressants increase risks for elderly (3 August 2011 PA 237/11)
QFracture validated as a key tool for clinicians (12 July 2011)
QFeedback: New tool will help GP monitor flu rates (4 January 2011)
QKidney: New score for GPs to predict kidney disease risk (29 June 2010)
QResearch reveals adverse side effects of heart disease drugs (1 June 2010)
QRisk2 now available as open source software (17 May 2010)
New tool will help GPs monitor flu rates (20 January 2011 PA 07/10)
New QRISK Score to predict heart disease in younger people (9 December 2010 PA 352/10)
Newer antipsychotic drugs could raise risk of dangerous blood clots (22 September 2010 PA 251/10)
New score for GPs to predict kidney disease risk (21 June 2010 PA 150/10)
National database launches more detailed swine flu reports (17 July 2009)
New research to reduce drug side-effects (9 July 2009 PA 189/09)
New heart disease risk score outperforms existing test (8 July 2009 PA 186/09)
New score for GPs will detect patients at high-risk of diabetes (18 March 2009 PA 68/09)
GP software 'to prevent heart disease' (4 February 2009 PA 30/9)
Primary Care records improve public health information (7 October 2008 PA 240/08)
New cardiovascular score developed to improve heart attack and stroke detection (27 June 2008 PA 141/08)
Working GPs provide data for BMJ research paper (26 March 2007)
GPs sign up to report on flu epidemics (29 September 2005)
World's largest research database to detect epidemics (31 January 2005)
›